As mentioned before, MATP loss of cancer cells leads to the accumulation of its substrate MTA and further inhibits the activity of arginine methyltransferase, which causes the heightened susceptibility to the PRMT5 depletion and impairs the cancer cell viability through synthetic lethality machinery (139, 140). This evidence concerns the gene PRMT5 and cancer.